(BV) is a violation of the vaginal ecosystem characterized by a shift in vaginal flora is usually dominated by one dominant Lactobacillus sialidazy enzyme producing mixed flora. This is the most common cause of abnormal vaginal discharge in adult women. System BVBlue (Gryphus Diagnostics, Ltd.) is a diagnostic test Chromogenic depending on the availability of high enzyme sialidazy in vaginal fluid samples. BVBlue was compared with a standard method for diagnosing BV (Amselem criteria and rating Nugent). Fifty-seven nonmenstruating women aged 16 years who presented for gynecological examination were recruited. Demographic indicators were collected by self-questionnaire. Amselem evaluation criteria based on three of the four following characteristics of vaginal discharge: consistency, odor, pH and presence of key cells per gram. BVBlue was compared with Gram and Amselem criteria. Sensitivity, specificity, positive predictive value and negative predictive value for BVBlue against Gram and Amselem criteria 91. 7, 97. 8, 91. 7 and 97. 8% and 50. 0, 100, 100 and 88. 2%, respectively. Significantly more patients with vaginal pH 4. 5, positive amine test, or the key cells in the vaginal smear Gram-negative, it was found that the positive test BVBlue (
P 0. 001). Women who have strattera price previously received for BV were 2. 98 times more likely to be another episode of BV. BVBlue useful point-of-care diagnostics for possible diagnosis of BV, especially in situations where microscopic capabilities are unavailable. .
No comments:
Post a Comment